Showing results (21-30 of 229) with videos related to
Sort By:
Pageof 23
Blood|April 9, 2015
How I treat refractory and early relapsed acute myeloid leukemiaFelicitas Thol, Richard F Schlenk, Michael Heuser, et al.Biometrical Journal. Biometrische Zeitschrift|September 26, 2019
Adjusting Simon's optimal two-stage design for heterogeneous populations based on stratification or using historical controlsDominic Edelmann, Christina Habermehl, Richard F Schlenk, et al.Current Hematologic Malignancy Reports|May 22, 2015
Minimal residual disease in acute myeloid leukemia--current status and future perspectivesSabine Kayser, Roland B Walter, Wendy Stock, et al.Current Opinion in Oncology|September 1, 2017
Relapsed/refractory acute myeloid leukemia: any progress?Richard F Schlenk, Carsten Müller-Tidow, Axel Benner, et al.Leukemia|January 18, 2019
Targeting FLT3 mutations in AML: review of current knowledge and evidenceNaval Daver, Richard F Schlenk, Nigel H Russell, et al.Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 30, 2023
Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic DonorsSabine Kayser, Richard F Schlenk, Marcus Steiner, et al.Blood|September 1, 1992
Contact-induced neutrophil activation by platelets in human cell suspensions and whole bloodA Ruf, R F Schlenk, A Maras, et al.Plos One|May 10, 2016
Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable ModelingStefanie Hieke, Axel Benner, Richard F Schlenk, et al.Haematologica|December 7, 2005
The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemiaClaudia Scholl, Richard F Schlenk, Karina Eiwen, et al.Haematologica|October 18, 2006
JAK2V617F mutations as cooperative genetic lesions in t(8;21)-positive acute myeloid leukemiaKonstanze Döhner, Juan Du, Andrea Corbacioglu, et al.Pageof 23